News & Updates

Evinacumab hits mark in difficult-to-treat children with rare lipid disorder

The angiopoietin-like 3 inhibitor evinacumab appears to reduce low-density lipoprotein cholesterol (LDL-C) levels in children with homozygous familial hypercholesterolemia (HoFH) and persistently high LDL-C despite optimized therapy.

Is it safe to prescribe OACs to older patients with AF?

Older patients who are taking oral anticoagulants (OAC) for atrial fibrillation (AF) benefit from a reduced risk of stroke and all-cause mortality, reports a study. Moreover, nonvitamin K oral anticoagulants (NOAC) exhibit superiority over vitamin K agonists (VKA), with less mortality and major bleeding among its users.

Kids living near green spaces have higher BMD

Early exposure to green spaces may positively influence children’s bone health during crucial periods of growth and development, according to a new study.

Hydroxychloroquine does little to prevent pre-eclampsia in pregnant women with lupus

The use of hydroxychloroquine during pregnancy does not appear to reduce the risk of pre-eclampsia among women with systemic lupus erythematosus, as shown in a study.

Robust evidence for fenofibrate in patients with metabolic syndrome on statins

Comorbid sleep-disordered breathing and AF poststroke linked to elevated mortality, recurrence

Stroke patients with comorbid moderate-to-severe sleep-disordered breathing (SDB) and atrial fibrillation (AF) are at heightened risk of long-term mortality or recurrent cerebro-cardiovascular events, according to a study.

Kiwifruit confers rapid mood-lifting effect

Eating kiwifruit appears to improve mood in as little as 4 days.